Highlights
Fincons Group and the Municipality of Bari deliver Smart Working
Part of the European Commission funded CITADEL project for Public Sector transformation, the partnership delivers innova
Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan P
Audience: Consumer, Health Professional, Pharmacy April 18, 2019 -- Torrent Pharmaceuticals Limited is expanding its rec
MedHealth Summit Brings Together Cross-Border Innovators and Experts
As the healthcare industry continues to undergo technology-driven changes, innovators in digital health and medical devi
FDA Orders Boston Scientific and Coloplast to Remove All Remaining Vaginal Mesh Products f
Manufacturers of the surgical mesh devices have not provided reasonable assurances of safety and effectiveness, accor
How do I boost low staff morale?
Three pharmacy managers provide their thoughts and advice to a colleague who is concerned about staff satisfaction and e
Growth in Medical Devices Spurs Recruitment Challenges
In addition, in workforce optimization, retention plays an equally important role as recruitment.
nlThe post
Growth in Medical Devices Spurs Recruitment Challenges
In addition, in workforce optimization, retention plays an equally important role as recruitment.
nlThe post
Worldwide first and only shotgun lipidomics service provider with official GMP certificate
Dresden / Germany, 16th April 2019 Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical produc
17th Annual Pharmaceutical IT and Data Congress
We will welcome over 450 attendees representing global pharmaceutical organisations, leading biotech companies and inter
Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3
CAMBRIDGE, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic med
AveXis Data Reinforce Effectiveness of Zolgensma in Treating Spinal Muscular Atrophy (SMA)
Basel, April 16, 2019 - AveXis, a Novartis company, today announced that interim data from its Phase 3 STR1VE trial of Z